27282-89-9

Basic information

• Product Name: 4-(methylthio)-1,3,5-triazin-2-amine
• Synonyms: 4-(methylthio)-1,3,5-triazin-2-amine;Albb-008401;4-(methylthio)-1,3,5-triazin-2-amine(SALTDATA: FREE)
• CAS NO: 27282-89-9
• Molecular Formula: C4H6N4S
• Molecular Weight: 142.18
• Mol File: 27282-89-9.mol
• Article Data: 3

Chemical Properties

• Melting Point: 239-241 °C
• Boiling Point: 392.1°C at 760 mmHg
• Flash Point: 190.9°C
• Appearance: /
• Density: 1.38g/cm³
• Vapor Pressure: 2.34E-06mmHg at 25°C
• Refractive Index: 1.629
• PKA: 3.08±0.10(Predicted)
• CAS DataBase Reference: 4-(methylthio)-1,3,5-triazin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(methylthio)-1,3,5-triazin-2-amine(27282-89-9)
• EPA Substance Registry System: 4-(methylthio)-1,3,5-triazin-2-amine(27282-89-9)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 27282-89-9(Hazardous Substances Data)

Usage

General Description

4-(Methylthio)-1,3,5-triazin-2-amine is a chemical compound with the molecular formula C4H7N5S. It is a triazine derivative that contains a thioether functional group, which is a sulfur atom bonded to a carbon atom. 4-(methylthio)-1,3,5-triazin-2-amine is used in organic synthesis and as a building block in the production of various pharmaceuticals, agrochemicals, and dyes. Its properties make it useful in the development of new materials and chemical processes. Additionally, the presence of the amine group allows for further derivatization and modification to create a wide range of related compounds with different properties and potential applications.

InChI:InChI=1/C4H6N4S/c1-9-4-7-2-6-3(5)8-4/h2H,1H3,(H2,5,6,7,8)

Upstream product

• 36469-86-0 4-amino-1H-[1,3,5]triazine-2-thione 
• 74-88-4 methyl iodide 
• 85302-07-4 2-(dimethylaminomethylene)cyclohexane-1,3-dione 
• 4338-95-8 S-methylthiouronium iodide 
• 2986-19-8 carbamimidothioic acid methyl ester 
• 77287-34-4 formamide 

Relevant articles and documents

NOVEL COMPOUNDS

The invention relates to pyridine derivatives of formula (I) where the variables are defined in the specification.Processes for the preparation of these compounds together with pharmaceutical compositions containing them and their use in therapy in particular in the modulation of autoimmune disease is also described.

Synthese regiospecifique d'acyl-4 pyrazoles a partir d'acyl-5 pyrimidines

The transformation of variously substituted 5-acetyl-4-methylpyrimidines 1 into 4-acetyl-1-amidino-3-methylpyrazole amidinohydrazone dihydrochloride 3, under the action of amidinohydrazine hydrochloride, in boiling acidic methanolic solution, depends on the nature of the 2-substituent of pyrimidines 1, and on the stability of the amidinohydrazone of pyrimidines 2 under the reaction conditions.Phenylhydrazine transforms all the pyrimidines 1 into pyrazoles, regiospecifically or not, according to the nature of the 2-substituent of pyrimidines 1.This new possibility of ring contraction has been extended to other unsymetrical 5-acyl- and 5-ethoxycarbonylpyrimidines.